Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice

Area of Science:

• Cardiovascular Research
• Infectious Disease Research
• Atherosclerosis Pathogenesis

Background:

• Seroepidemiological studies suggest a link between Chlamydia pneumoniae (CP) and coronary heart disease (CHD).
• Experimental data indicate CP may promote or initiate atherosclerosis.
• The role of CP in atherosclerosis requires further investigation in relevant models.

Purpose of the Study:

• To evaluate the impact of CP infection on atherosclerosis development.
• To assess CP's effect in atherosclerosis-prone apolipoprotein E-knockout (apoE-KO) mice.
• To determine if CP induces atherosclerosis in wild-type mice.

Main Methods:

• Female apoE-KO and C57BL/6J mice were infected intranasally with live CP.
• Mice were maintained on a standard chow diet for 22 weeks post-infection.
• Infection confirmation via PCR and immune response assessment using ELISA.

Main Results:

• CP infection was confirmed in mouse lungs with a detectable humoral immune response.
• No significant difference in aortic atherosclerotic lesions was observed between CP-infected and control apoE-KO mice.
• CP infection did not induce atherosclerosis in wild-type C57BL/6J mice.

Conclusions:

• CP does not induce atherosclerosis in wild-type mice.
• CP does not accelerate atherosclerosis in chow-fed apoE-KO mice.
• The association between CP and human CHD remains to be clarified by future studies.